Brawn Biotech Limited (BOM:530207)

Market Cap	60.40M -4.1%
Revenue (ttm)	172.71M +17.9%
Net Income	-790.80K
EPS	-0.27
Shares Out	3.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	122
Open	20.50
Previous Close	20.55
Day's Range	20.13 - 20.50
52-Week Range	16.15 - 24.37
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Brawn Biotech

Brawn Biotech Limited engages in the trading of pharmaceutical products in India. It provides pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. The company was incorporated in 1985 and is based in New Delhi, India.

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 9
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530207

Financial Performance

In fiscal year 2025, Brawn Biotech's revenue was 134.75 million, a decrease of -18.30% compared to the previous year's 164.95 million. Losses were -17.40 million, 39.5% more than in 2024.